From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience

Citation
C. Germinario et al., From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience, VACCINE, 18, 2000, pp. S83-S85
Citations number
2
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
18
Year of publication
2000
Supplement
1
Pages
S83 - S85
Database
ISI
SICI code
0264-410X(20000218)18:<S83:FHBTHA>2.0.ZU;2-W
Abstract
The incidence of hepatitis B virus infection in Italy is 10 per 100,000 pop ulation, with most cases occurring in young adults. Vaccination against hep atitis B has been compulsory since 1991 for all newborns and 12-year-olds. In the Puglia region, this programme has reduced the incidence of hepatitis B from 7.4 per 100,000 population in 1990 to 2.4 per 100,000 population in 1996, The number of notified cases of hepatitis B in Puglia decreased from 212 in 1992 to 73 in 1997. As 50% of these cases occurred in young adults, the main aim of the current vaccination programme is to achieve high cover age rates among teenagers and young adults within the next few years. Altho ugh the incidence of hepatitis A is only about 5 per 100,000 overall in Ita ly, Puglia is an area of intermediate endemicity with a seroprevalence of a ntibodies to hepatitis A virus (anti-HAV) of about 40% in 18-year-olds. The incidence of hepatits A is up to 30 per 100,000 between the periodic outbr eaks that occur every 2-4 years. Most notified cases occur in adolescents a nd young adults. The last outbreak of about 11,000 cases of hepatitis A in the Puglia region occurred in 1996-1997, mainly in the summer months in tow ns with harbours or near the coast. The most important risk factor was init ially consumption of raw seafood, but later was personal contact, probably between children. A vaccination programme against hepatitis A was initiated in Puglia in 1997, aiming to vaccinate all infants of 15-18 months and all 12-year-olds against hepatitis A. Infants receive monovalent hepatitis A v accine with the first dose of mumps/measles/rubella vaccine. Monovalent hep atitis vaccine can be given with the second and third doses of hepatitis B vaccine in 12-year-olds, but use of combined hepatitis A and B vaccine is r ecommended to aid compliance and reduce the commitment of physician/nurse t ime. Vaccination can be performed in school. (C) 2000 Elsevier Science Ltd. All rights reserved.